Before reading the job post, we encourage you to watch this video about our company. It gives you an inside look at how we started, the team and culture that made us successful, and where we're going. It's easy to read a job post and apply, but people often wonder about the culture and whether they would fit in. If you want to call Harrow your home and genuinely want to be part of a family and something big, then we encourage you to click this link and get to know us.
Who is Harrow?
Harrow (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America. Harrow is an incredible entrepreneurial company – where we celebrate the ability of every member of the Harrow Family to be the CEO of their job. Harrow’s values have driven interest over the past decade in attracting high-performing professionals in a variety of disciplines. Members of our Harrow Family often express their pride in being a part of our commitment to (1) innovation, (2) patient access to affordable medicines, and (3) our track record of having never turned down an ophthalmologist doing mission work around the world – providing free medicines in support of mission work aimed at giving or maintaining the gift of sight to those most in need. We encourage you to learn more about Harrow and its unique culture to see if you’re the right person to help contribute as we build a truly exceptional company, one we are all so proud of!
Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including:
- An expanding Retina Portfolio including IHEEZO®, TRIESENCE®, BYOOVIZTM, and OPUVIZTM
- A broad Dry Eye Disease product line, led by VEVYE® and bolstered by well-known adjacent ocular surface disease products such as FLAREX® and FRESHKOTE®
- A peri-operative Surgical product line, led by TRIESENCE®, and BYQLOVITM
- A Rare and Specialty product line, which includes various high-need and utility products such as ILEVRO®, NATACYN®, and VERKAZIA®
- A robust internal development pipeline with multiple late-stage candidates, including MELT-300, MELT-210, H-N08, and CR-01
Job Summary
The Marketing Lead, Retina is the strategic and executional lead for Harrow’s Retina portfolio, including IHEEZO®, TRIESENCE®, BYOOVIZ™, and OPUVIZ™. This role owns end-to-end marketing strategy and execution across brands, driving growth through integrated HCP and patient marketing programs.
Core Responsibilities
Retina Brand Leadership
- Lead marketing strategy, positioning, and annual brand planning across the Retina portfolio
- Identify growth opportunities and drive demand across care settings
- Support product launches and lifecycle initiatives
Integrated Marketing Execution
- Own execution of omnichannel campaigns across personal and non-personal channels (sales, digital, media, CRM)
- Develop HCP and patient marketing programs to drive awareness and adoption
- Oversee content, messaging, and field-facing tools
Performance & Analytics
- Define KPIs and measure campaign effectiveness
- Use insights to optimize performance and inform strategy
Cross-Functional Leadership
- Partner with sales, medical, regulatory, legal, and market access to ensure aligned, compliant execution
- Lead promotional review and ensure high-quality deliverables
Agency & Operations
- Manage agencies and vendors to deliver programs on time and within budget
- Oversee marketing budgets and multiple concurrent initiatives
Qualifications & Requirements
- Bachelor’s degree required, MBA preferred
- 10+ years pharma/biotech marketing experience
- Strong HCP marketing and brand leadership experience
- Proven success leading integrated, omnichannel campaigns
- Ophthalmology, retina, or buy & bill experience required
Position Type
- Remote
Travel
- 35-50%
Top Skills
Similar Jobs
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering
